Next Article in Journal
Hepatitis B Virus X Protein Induces Reactive Oxygen Species Generation via Activation of p53 in Human Hepatoma Cells
Previous Article in Journal
Correction: Geng et al. Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L. Biomolecules 2020, 10, 217
Previous Article in Special Issue
ORAI Ca2+ Channels in Cancers and Therapeutic Interventions
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Deep Dive into the N-Terminus of STIM Proteins: Structure–Function Analysis and Evolutionary Significance of the Functional Domains

by
Sasirekha Narayanasamy
,
Hwei Ling Ong
and
Indu S. Ambudkar
*
Secretory Physiology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892-1190, USA
*
Author to whom correspondence should be addressed.
Biomolecules 2024, 14(10), 1200; https://doi.org/10.3390/biom14101200
Submission received: 20 August 2024 / Revised: 17 September 2024 / Accepted: 18 September 2024 / Published: 24 September 2024
(This article belongs to the Special Issue Role of STIM and Orai in Calcium Signaling)

Abstract

:
Calcium is an important second messenger that is involved in almost all cellular processes. Disruptions in the regulation of intracellular Ca2+ levels ([Ca2+]i) adversely impact normal physiological function and can contribute to various diseased conditions. STIM and Orai proteins play important roles in maintaining [Ca2+]i through store-operated Ca2+ entry (SOCE), with STIM being the primary regulatory protein that governs the function of Orai channels. STIM1 and STIM2 are single-pass ER-transmembrane proteins with their N- and C-termini located in the ER lumen and cytoplasm, respectively. The N-terminal EF-SAM domain of STIMs senses [Ca2+]ER changes, while the C-terminus mediates clustering in ER-PM junctions and gating of Orai1. ER-Ca2+ store depletion triggers activation of the STIM proteins, which involves their multimerization and clustering in ER-PM junctions, where they recruit and activate Orai1 channels. In this review, we will discuss the structure, organization, and function of EF-hand motifs and the SAM domain of STIM proteins in relation to those of other eukaryotic proteins.

1. Introduction

Calcium (Ca2+) is a versatile intracellular messenger that plays a crucial role in a myriad of cellular processes such as fertilization, cell differentiation, muscle contraction, cell motility, cellular metabolism, synaptic plasticity, RNA transcription, and secretion [1,2,3,4,5,6,7,8]. Abnormal Ca2+ signaling leads to severe pathological conditions such as ischemia, stroke, and autoimmune diseases, as well as immune deficiency. It has also been implicated in neurological disorders such as Alzheimer’s, Huntington’s, and Parkinson’s disease [9,10,11]. The mechanisms of intracellular Ca2+ signaling are diverse in different cell types, involving a number of molecular signaling components such as receptors, pumps, and effector molecules that are organized into functionally distinct combinations to mediate Ca2+ signaling as required for cell function [2]. Specific Ca2+ sensor proteins can transduce the initial Ca2+ signal into the regulation of multiple cellular functions. For example, local Ca2+ near the Orai1 channel is sensed by calmodulin (CaM) and utilized to regulate a variety of signaling processes, such as NFAT-dependent gene expression. On the other hand, global Ca2+ signals can be sensed by a different set of Ca2+ sensors and used to regulate other Ca2+-dependent cell functions. The magnitude and frequency of the Ca2+ signal, as well as its spatial organization, play key roles in the type of Ca2+ sensor involved.
As such, cells have several mechanisms to regulate cytosolic [Ca2+]i: (i) plasma membrane calcium channels mediate extracellular Ca2+ influx into the cytosol; (ii) sequestration of cytosolic Ca2+ into the intracellular organelles, such as the ER and mitochondria, via Ca2+ pumps and channels; (iii) extrusion of Ca2+ from the cytoplasm to the extracellular milieu via plasma membrane Ca2+ pumps and exchangers [12]. In unstimulated or resting cells, [Ca2+]i is maintained at a concentration between 10 and 100 nM. Following cell stimulation, [Ca2+]i can increase several folds depending on the stimulus intensity and type of cells [13]. Cells are equipped with the ability to sense and respond accordingly to physiologically low and relatively high stimulus intensities [12,14]. The Ca2+-binding proteins (CaBPs) function as Ca2+ buffers and sensors that respond to changes in the Ca2+ levels and activate a cascade of downstream effector molecules to transduce the signal into specific responses and prevent unregulated increases in [Ca2+]i. The Ca2+-binding affinities in these proteins are determined by specific motifs and domains [15,16].
Store-operated calcium entry (SOCE) is a ubiquitously present Ca2+ entry mechanism that regulates a variety of physiological functions [17,18]. SOCE was first identified by Putney, wherein depletion of ER-Ca2+ stores results in the activation of plasma membrane Ca2+ channels [19]. The cascade of steps that lead to SOCE starts with the stimulation of G-protein coupled receptors (GPCRs), activation of phospholipase C (PLC), and conversion of phosphatidylinositol-4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 binds to the IP3 receptor (IP3R) present on the ER membrane and elicits Ca2+ release from the ER into the cytoplasm, a process known as ER-Ca2+ store depletion [20,21]. While ryanodine receptors can contribute to IP3-induced Ca2+ store depletion via Ca2+-induced Ca2+ release or via IP3-independent mechanisms, this review focuses on the IP3R-mediated mechanism. SOCE is primarily dependent on the Ca2+-selective plasma membrane channel family, Orai, comprising Orais1, 2, and 3, and multi-domain Ca2+-binding proteins, stromal interacting molecules STIM1 and STIM2, which are single-pass transmembrane (TM) proteins in the ER membrane, with N-terminal EF-hands in the ER lumen that sense the decrease in [Ca2+]ER. STIM1 and Orai1 form the elementary units for SOCE, with the Orai1 channel mediating the Ca2+ selective Ca2+ current (ICRAC). In unstimulated or resting cells, STIM1 is diffused throughout the ER and also tracks along the microtubules by interacting with the EB1 protein. Orai1 is freely diffused in the plasma membrane. Following ER-Ca2+ store depletion, STIM1 loses the Ca2+ bound to its canonical EF (cEF)-hand, which triggers a conformational change both in its N and C termini, causing the protein to dimerize and translocate to the ER-plasma membrane junctions (ER-PM junctions). Orai1 is recruited into these junctions and gated via interactions with STIM1 [22,23,24]. On the other hand, STIM2 is already pre-clustered in the ER-PM junctions in unstimulated/resting cells, which further increases following ER-Ca2+ store depletion. STIM2 also recruits and activates Orai1, albeit with lower efficiency and at different stimulus intensities when compared to STIM1 [17,25,26] (Figure 1).
There is considerable interest in elucidating the structure-to-function relationship of STIM and Orai proteins, judging from the large number of publications in the past two decades. This review will discuss the N-terminal domain of the STIM proteins, elaborating on the structural organization and evolutionary significance of the EF-hand and SAM domains. Even though both STIMs can also interact with Orai2 and Orai3, this review will only focus on STIM–Orai1 interactions while briefly describing the evolution of Orai channels.

2. Components of Store-Operated Calcium Entry (SOCE)

Orai1 was discovered in an RNAi-based screen of SOCE components in Drosophila S2 cells and linkage analysis of patients with severe combined immunodeficiency [29,30,31,32]. Almost all invertebrates, such as nematodes, fruit flies, mosquitoes, sea urchins, and seq squirts, have a single Orai protein. This evolved into Orai1 and Orai2 in vertebrates, as shown for fish and frogs. Orai3 is formed via duplication of the Orai1 gene and is exclusive to mammals [29,33,34]. Unlike Orai1, the knockdown of Orais 2 and 3 did not abrogate SOCE and ICRAC. Nonetheless, both Orais contribute to other (non-SOCE) types of Ca2+ influx [34]. All three Orais show near complete conservation within the pore-lining TM1 and highly identical TMs 2 to 4 but diverging cytosolic N- and C-termini sequences. There are 34% and 46% sequence similarity in the N- and C-termini of Orais 1 and 3. Additionally, Orai3 exhibits a longer third extracellular loop than Orais 1 and 2 [33,34,35]. Orai1 has two isoforms, Orai1α (longer, approximately 33 kDa) and Orai1β (lacks 63 aa in the N-terminus). Orai1β arose from an alternative translation initiation site in Orai1α and did not contain a poly-arginine sequence suggested to mediate Orai1 interaction with plasma membrane PIP2. As such, Orai1β exhibited faster mobility than Orai1α, but it was unclear how that would impact channel function since both isoforms generated similar magnitudes of SOCE and ICRAC. Interestingly, Orai1α and Orai1β form only homomeric CRAC channels [33,34,36]. In a study using a weaker TK promoter to drive Orai1 expression in mouse embryonic fibroblasts from Orai1−/− mice (Orai1-KO MEFs), both isoforms restored ICRAC in Orai1-KO MEFs to similar levels in wild-type MEFs. Orai1α-mediated ICRAC exhibits a faster CDI as rapid inactivation was observed with EGTA (slower chelator) but not BAPTA (fast chelator). However, no difference was observed for Orai1β-mediated ICRAC. Both Orai1α and Orai1β supported ISOC when co-expressed with TRPC1 and STIM1, but only Orai1α contributed to IARC (arachidonic acid-induced current). The authors proposed that mammalian evolution exploited the process of alternative translation start sites to generate different isoforms of the same channel with distinct modes of regulation and contribution to cellular processes [33,34,37].
Orai arose earlier than STIM during evolution and may have initially contributed to non-IP3-mediated calcium influx. When STIM arose as a complement to IP3/IP3R signaling, the existing Orai channels may have been co-opted for SOCE [12,38,39,40]. The key residue controlling Ca2+ selectivity (E106 in Orai1) is conserved in many species, suggesting that Orai proteins have long functioned as highly Ca2+-selective channels [12]. TBlastN searches using Caenorhabditis elegans Orai protein revealed a putative cation transporter (PfuCaT) from the genomic sequence of Pyrococcus furiosus, with homologs of PfuCaT also present in Pyrococcus horikoshii and Thermococcus kodakaerensis. All three cocci are hyperthermophilic archaea found in isolated environments with high temperatures. While Orai has four TMs, PfuCaT has five, with TM1 linked by a large hydrophilic loop to the rest. Nonetheless, PfuCaT shares a highly conserved signature motif with two internal repeats containing two key residues essential for Ca2+ selectivity (similar to E106 and E190 in Orai1). Since there is limited sequence similarity outside of the signature motif, PfuCaT is likely to have different regulatory mechanisms than Orai. Notably, sequences similar to the coiled-coil ezrin–radixin–moesin (ERM) domain of STIM1 have been found in hyperthermophilic archaea genomes, suggesting that both Orai and STIM proteins may have adapted existing domains to support SOCE during the transition to metazoans [29,41]. While Orai proteins in nematodes and insects have a long N-terminus and short TM3-TM4 loop, those in ascidians, non-mammal vertebrates, and mammals have a short N-terminus but longer TM3-TM4 loop. For example, the N-termini of C. elegans and Drosophila melanogaster Orai1 have 119 aa and 160 aa c.f. 66 aa in Ciona intestinalis (sea squirt). Orai3, which is mammalian-specific, has the longest TM3-TM4 loop (72 aa) c.f. C. elegans (13 aa) and D. melanogaster (9 aa). The author proposed that changes in the lengths of the N-terminus and TM3-TM4 loop reflect functional evolutionary changes between species [29].
STIM proteins were discovered by two independent groups using RNAi screens to identify SOCE components. Roos et al. identified the role of STIM in SOCE by knocking down the expression of STIM in lower eukaryotes, such as in fruit flies and D. melanogaster [42]. The second group used gene silencing techniques to identify both homologs of STIM (STIMs 1 and 2) that are involved in sensing ER-Ca2+ store depletion and SOCE in HeLa cells [43]. In higher organisms such as vertebrates, starting from fishes, STIM proteins have evolved into two types: STIM1 and STIM2 [12]. While gene localization studies indicate that STIM1 and STIM2 are localized in chromosomes 11 and 4, respectively, both proteins share high sequence and structural similarity. The functional regions of vertebrate STIM consist of identical domains such as the N-terminal EF-SAM domain in ER lumen, a single-pass ER-TM, followed by cytosolic coiled-coil domains, a STIM-Orai activating region (SOAR), a Serine/Proline-rich (in STIM1) or Proline/Histidine-rich (in STIM2) domain, and a polybasic domain in the C-terminus. Nonetheless, these homologs have evolved to perform different functions. STIM1 has a high Ca2+-binding affinity endowed by its canonical EF (cEF) hand and requires substantial ER-Ca2+ store depletion to be activated. Conversely, the cEF-hand of STIM2 has a lower affinity that enables the protein to sense smaller levels of ER-Ca2+ store depletion. The sensing of sub-threshold stimuli by STIM2-cEF-hand results in the immobilization of STIM2 clusters within the ER-PM junctions in resting cells. As such, both proteins behave differently in resting cells where STIM2 is already pre-clustered in the ER-PM junctions but not STIM1. Moreover, the SOAR of STIM2 is a weaker activator of Orai1 when compared to STIM1. STIM2 contributes to constitutive or basal Ca2+ entry in resting cells by interacting with and gating Orai1. Notably, pre-clustered STIM2 can recruit STIM1 through the C-terminal coiled-coil domain interaction in the cytoplasm and enhance STIM1/Orai1 coupling in cells with relatively high [Ca2+] in the ER lumen ([Ca2+]ER), such as in resting cells or when cells are stimulated with relatively low [agonist] [26,44,45,46,47]. Therefore, the N-terminal region of STIM proteins plays an important role in transducing stimuli into SOCE activation. The three-dimensional structures reported for human STIM1 (PDB: 2K60) and STIM2 (PDB: 2L5Y) contain a canonical and a non-canonical EF-hand motif followed by the sterile-α-motif (SAM) [27,28]. In the following sections, we will discuss the structural organization of EF-hand motifs and SAM domains present in STIMs in relation to other CaBPs and multi-domain-containing eukaryotic proteins.

3. EF-Hand Motifs in Calcium-Binding Proteins: Overview and Properties

The EF-hand motif was first identified by Kretsinger while determining the structure of parvalbumin [48]. This motif is ~30 amino acids in length and folds into two α-helices (entering (E) and exiting (F) helices), which are almost perpendicular to each other in Ca2+-bound form. These helices are connected by a 12-residue Ca2+-binding loop that coordinates Ca2+ by attaining a pentagonal bipyramidal geometry [48]. This motif has been identified in several CaBPs, including ELC, RLC, troponin C, and CaM. About 156 subfamilies of EF-hand motifs and 3000 EF-hand-related entries can be found in the NCBI Reference Sequence Database [49,50]. Intriguingly, some CaBPs encompass only EF-hand motifs (e.g., CaM [51], troponin C [52], calumenin [53]), while in other proteins, EF-hand motifs are part of a large multi-domain protein. In those latter proteins, EF-hand motifs are found either at the N-terminal, middle, or C-terminal region of the protein [49,54]. While EF-hands are associated with the SAM domain in STIM proteins, other EF-CaBPs have cysteine protease, leucine zipper domain, and coiled coil domain associated with it [27,28,55,56,57]. Two adjacent EF-hand motifs organized into a four-helix bundle domain and occurring in pairs are known as the EF-hand domain, which is observed in many proteins, including troponin C [52,58], calbindin D9k [59], and SCP [60]. A central hydrophobic core formed by domain packing of the E and F helices drives the dimerization of EF-hand motifs [61,62]. An anti-parallel β-sheet established between the EF-hand loop sequences additionally stabilizes its structural integrity, a common property that is present in many EF-hand proteins [50,63]. The EF-hand domains are arranged into different spatial conformations that primarily depend on the length of a linker region connecting the two EF domains. For example, the four Ca2+-bound EF-hand motifs of calmodulin (CaM) are arranged into two N and C-terminal EF-hand globular domains connected by a linker [51,64]. The essential function of the EF-hand motifs is to translate the changes in the local Ca2+ concentration into a physiological response. EF-hand motifs exhibit diversity in order to achieve versatility with regards to structure, Ca2+-binding, conformations, and domain organizations [61,65]. These motifs bind Ca2+ with dissociation constants (KD) ranging from 10−9 to 10−4 M. The Ca2+ binding affinities vary among the EF-hand proteins and primarily arise from different amino acids found in the loop region and their intermolecular interactions with target proteins [63]. The EF-hand motifs possess diverse metal ion bind properties and can bind other similar-sized cations, such as Mg2+, to form a Ca2+/Mg2+ mixed site [66,67,68]. However, EF-hand motifs adopt different geometries accordingly. Whereas Ca2+ is bound by seven ligands in the EF-hand loop arranged in a pentagonal bipyramidal configuration, Mg2+ utilizes only six ligands to form an octahedral coordination scheme [63,69].

3.1. Structural Response to Ca2+-Binding and the Stability

EF-hand motifs undergo conformational/structural changes upon coordinating Ca2+, which is then recognized by target effector molecules to relay the Ca2+ signals. These Ca2+-induced structural changes have been well documented for several CaBPs using biophysical techniques, molecular dynamics simulation, and other structural characterization methods. Based on the Ca2+-induced conformational changes, they are classified into two classes: Ca2+ sensors and Ca2+ buffers. The key property of Ca2+ sensors is their ability to undergo major conformational changes upon binding Ca2+ and present an open conformation with their hydrophobic pocket exposed to the solvent, which serves as a target protein recognition and interaction site [50]. Ca2+ binding-induced transition from a closed to an open conformation has been reported for CaM [70], troponin C [71], and S100 family members [72]. Ca2+ buffers are a small population of cytosolic Ca2+-binding proteins that undergo very little/no conformational changes upon Ca2+-binding (e.g., calbindin (D9k, D28k), α and β-parvalbumin, and calretinin [73,74]) and regulate short-lived Ca2+ signals by modulating their spatial–temporal aspects [50,75]. The ability of these types of Ca2+- buffers to modulate intracellular Ca2+ signaling depends on several factors, such as Ca2+ concentration, affinity to bind Ca2+ (and other similar metal ions), Ca2+-binding kinetics, and mobility of both Ca2+-buffering proteins and the Ca2+ ions [75].

3.2. Diversity of the Amino Acids in the Loop Region

The loop region that connects the E and F helices of an EF-hand motif contains 12 amino acid residues that are arranged in a pentagonal bipyramidal fashion to coordinate a single Ca2+ ion. The assignment of the amino acids in a typical EF-hand motif is as follows: 1(+X), 3(+Y), 5(+Z), 7(−Y), 9(−X), and 12(−Z), where the numbers indicate the position of amino acids in the loop that contribute oxygen (O) atoms to coordinate Ca2+ and the axes within brackets indicate their tertiary geometry in a pentagonal bipyramidal configuration. The Ca-O bond stabilizes this interaction, wherein the oxygen is provided by the main-chain carbonyl oxygen atoms, side chains of the following amino acids such as Asp, Asn, Glu, Gln, and Ser, and a water molecule [62,76]. Therefore, the loop regions of EF-hand motifs are rich in polar and negatively charged amino acids. Of note, a web of hydrogen bonds stabilizes the Ca2+ coordination sphere in addition to the Ca-O bond and diminishes the electrostatic repulsion of the negatively charged amino acids in the loop region [63]. The EF-loops of the Ca-binding proteins are divided into two types based on length, amino acid composition, and tertiary geometry, namely canonical and non-canonical loops. The canonical loop in an EF-hand motif contains 12-mer that contributes to protein stabilization and helps to maintain the overall domain fold. The importance of amino acid residues found at each position is discussed below. The first (X) and third (Y) positions in an EF-loop participate in the stereochemical arrangement of the loop and are occupied by Asp at a relatively higher frequency than any other amino acids. Similarly, Asp occupies the 5th (Z) position in an EF loop. The 6th position in an EF-hand loop usually contains Gly (96%), which provides an uncommon main chain conformation to bend the loop at an angle of ~90° that enables the remaining Ca2+ ligands to occupy the coordinating position [50,63,76]. Nonetheless, amino acids other than Gly have been reported in EF-hand motifs of polycystin-2 (PC-2) and calumenin at the 6th position, wherein the presence of amino acids other than Gly has been found to have a dramatic effect on the Ca2+-binding affinity and protein folding [77,78]. The following hydrophobic amino acids, Ile, Val, and Leu, occupy the 8th position in the loop, which enables the formation of a short anti-parallel β-sheet that is crucial for dimerization of the EF-hand motifs to form an EF-hand domain. The 9th position (−X) is preferably occupied by Asp, which chelates the Ca2+ ion through hydrogen bonding or a bridging water group. In addition, the amino acid at the 9th position initiates the F helix, which is stabilized by additional hydrogen bonding provided by the side chain of the Glu at the 12th position (−Z) [50,62,76]. Hence, the amino acids present in the EF-loop regions are of key importance in not only chelating metal ions but also stabilizing the structure of the EF-hand motif.
Despite this, several EF hands have been reported to coordinate Ca2+ through an uncommon mechanism and are called non-canonical EF (nEF) hands. These nEF-hand loops vary in amino acid composition and length, contributing to the functional diversity of EF-hands [63]. For example, nEF-hand motif 3 (EF3) of calcium and integrin binding protein (CIB) possesses a similar length in the loop region but with Asp instead of Glu at the 12th position. This results in a shorter EF3 loop and has an impact on the Ca2+ coordination sphere as well as ion selectivity [79,80,81]. In some nEF-hands, the Ca2+ coordination loop is longer than a typical cEF-hand due to the insertion of additional amino acids (e.g., EF5 of ALG-2). In such EF-loops, Ca2+ is chelated only by the N-terminus of the loop and by an additional water molecule [82]. Interestingly, some of the nEF-hands are shorter than the normal length and contain only eleven residues within the loop. Examples of this type are observed in the EF-hand of calpain domain VI, where the absence of the canonical 1st and 3rd Ca2+-ligands is compensated by oxygens contributed by the main chain carboxyl groups and water molecules [83].

3.3. Organization of EF-Hands in STIM Proteins

The N-terminal region of STIM proteins, consisting of nEF and cEF motifs as well as the SAM domain, share high sequence homology and similar domain architecture. Studies have reported that the N-terminal of STIM1 plays a crucial role in SOCE, as mutations in the EF-hands or SAM show major differences in physiological function [18]. Purified recombinant EF-SAM region of STIM1 elutes as a dimer or oligomer in the absence of Ca2+. However, in the presence of Ca2+, the protein elutes in a monomeric form. Consistent with this, secondary structure determination using far-UV CD spectroscopy indicates that the EF-SAM exists in a random coil-like conformation, and STIM1 adopts an α-helical structure upon binding Ca2+ [27,84]. This Ca2+-induced structural transition is a signature of many EF-hand-containing Ca2+-sensor proteins, where the Ca2+-induced structural transitions play an important role in protein–protein interaction and target recognition [85,86]. In addition, Ca2+-bound STIM1 (holo-STIM1) is more thermostable than Ca2+-free STIM1 (apo-STIM1), indicating that Ca2+-binding imparts structural stability. Furthermore, STIM1 binds Ca2+ with a relatively high affinity (KD ~200–600 mM) when compared to STIM2 [84,87]. Recent studies have shown that the GrpE-fused EF-SAM domain of STIM1 can bind ~5 Ca2+ ions/monomer as determined by isothermal titration calorimetry studies [88]. Consistent with this, molecular dynamics simulations showed the clustering of Ca2+ ions around the nEF-hand and SAM domain of STIM1, in addition to cEF-hand [89]. Interestingly, the binding of Ca2+ at these additional sites is solely dependent on the cEF-hand’s Ca2+-binding ability, as it is not detected in the case of the GrpE-fused D76A-EF-SAM mutant of STIM1 (which lacks the ability to bind Ca2+) [88]. Although STIM1 contains an EF-hand pair, the NMR structure indicates that it coordinates only one Ca2+ at the cEF-hand [87]. The nEF hand lacks the ability to bind Ca2+, which might be due to the presence of unconventional amino acids in its loop region (1st, 3rd, 6th, and 9th positions).
Atomic-level structural information available for the Ca2+-bound EF-SAM domain of STIM1 (PDB: 2K60) sheds light on the molecular details of the STIM1 [27]. The N-terminal region of EF-SAM is organized into a single globular domain containing predominantly α-helical secondary structural elements. The NMR structure shows a canonical helix–loop–helix Ca2+-binding EF-hand, a non-canonical EF-hand motif (also known as hidden EF-hand), and a SAM domain. Like other EF-hand pair-containing proteins, the cEF-hand of STIM1 also pairs with the nEF-hand. Of note, the NMR structure of STIM1 indicates that the second nEF-hand is stabilizing the cEF-hand via hydrogen bonding between the respective EF-loop regions (C(O) Val83, Ile115: N(H) Val 83, Ile115) and forming a small anti-parallel β-sheet, a property reminiscent of several EF-hand containing CaBPs [27,63,90]. In addition, Stathopulos et al. have reported that the STIM1 EF-hand pair shows high homology (structural alignment) to the C-terminal of Ca2+-bound bovine CaM. Also, vector-geometry mapping analysis measuring the interhelical angles between the E and F helices indicates that STIM1 EF-hands exist in an open conformation similar to that observed in Ca2+-bound CaM structures [27]. The open conformation of Ca2+-bound STIM1 may expose hydrophobic surfaces that pack against the non-polar surfaces of the SAM domain. However, as the apo-STIM1 structure has not been described yet, it is difficult to delineate how STIM1 structurally transitions from its apo to holo form.
To understand the evolutionary significance of EF-hands among the STIM1 orthologs, we performed multiple sequence alignment of STIM1 proteins from different species (Figure 2). Briefly, human STIM1 (Uniprotkb ID: Q13586) was used as a reference sequence and blasted against non-redundant sequences in the NCBI BLAST (protein blast)/Uniprotkb (Swissprot) server [91,92]. About ~154 STIM1 protein sequences were collected from different animals, and the sequences were checked for redundancy. Since STIM1 protein exists in different isoforms, only the longest isoform from each animal was used for multiple sequence analysis. We compared protein sequences from different animal species, such as monkeys, tortoises, turtles, mole rats, bats, squirrels, and lemurs, for similarities/differences. Only one unique representative protein sequence from each genus of the above-mentioned animals was used in the alignment. About ~70 STIM1 orthologous protein sequences were aligned using the MAFFT multiple sequence alignment tool [93]. MSA shows that STIM1 is an evolutionarily conserved protein among the metazoan tree of the family and is absent in plants, fungi, and bacteria. In the lower metazoans such as Arthropoda (D. melanogaster) and Nematoda (C. elegans, roundworm, etc.), STIM exists as a single copy [12,94]. Previous studies have shown that the STIM family might have undergone two rounds of gene duplication in vertebrates, one as early in the euteleostomi lineage and another within the fish genome [94], to give rise to STIM1 and STIM2 that perform different physiological functions. In the higher metazoans, such as in higher vertebrates, STIM1 is an evolutionarily conserved protein and can be found in different classes of Chordata phyla (i.e., mammals, birds, reptiles, amphibians, and fish). All STIM orthologs found in the Chordata phyla contain both the canonical and non-canonical EF hands. Comparing the 12-amino acid sequences of the cEF-hand loop of human STIM1 with other animals within the Chordata phyla, it is evident that the Ca2+ coordinating amino acids are 100% conserved except for the amino acid at the 7th position, wherein Asp (D) is replaced by Asn (N) in reptiles and birds and Ser (S) in zebrafish. On the other hand, STIM of the lower metazoans, such as D. melanogaster and nematodes, have Asn (N) and Ser (S), respectively, at that position. As few variabilities in the amino acids have been observed at the 4th, 10th, and 11th positions, the Ca2+-binding capacity of STIM1 is well-preserved during the evolution from lower organisms to higher metazoans.
It is hypothesized that Ca2+ binding to the nEF hand might have been lost during evolution. In our multiple sequence analysis (Figure 2), we found that the unusual amino acids in the 1st, 3rd, 6th, and 9th positions of the Ca2+-binding loop region are highly conserved in higher vertebrates. While few variations have been found in lower metazoans, such as in D. melanogaster, C. elegans, and worms, these are not equivalent to the amino acids observed in a typical Ca2+-binding cEF-hand such as in CaM or other canonical EF-hand motifs. Therefore, STIM1 likely evolved to accommodate only one functional Ca2+-binding EF-hand motif. Despite lacking the Ca2+ binding site, the nEF-hand motif might play an important role in maintaining the integrity of the EF-hand pair by pairing with the cEF-hand [27,88,89]. These observations indicate that the EF hands of STIM1 play an important role in Ca2+ sensing by the protein and its regulation of SOCE.
Although the EF-SAM domain of STIM2 possesses a high sequence identity (~58%) to STIM1, it differs in various biophysical and biochemical properties. In contrast to apo-STIM1, STIM2 is a natively folded protein and exhibits an α-helical secondary structural element in the absence of Ca2+, as determined by far-UV CD spectroscopy. Thermal denaturation studies indicate that apo-STIM2 retains its secondary structure and exhibits a higher melting temperature (Tm) when compared to apo-STIM1 [84]. Further addition of Ca2+ leads to minor changes in the CD spectra of STIM2, akin to the properties of several Ca2+-buffering proteins [75]. Although STIM2 does not undergo major conformational changes upon Ca2+-binding (as observed for STIM1), Ca2+-induced conformational spectral shifts were observed [84]. In addition, apo-STIM2 elutes at a slightly higher elution volume than holo-STIM2. These results indicate that apo-STIM2 exists in a slightly extended form, whereas holo-STIM2 is compact and well-folded. Furthermore, STIM2 binds Ca2+ with apparently low-binding affinity (KD of ~0.5–0.8 mM [28,44,84]) (c.f. KD of ~0.2–0.6 mM for STIM1 [84,87]).
The NMR structure of STIM2 EF-SAM (PDB: 2L5Y) reveals many interesting details about the domain organization of STIM2 [28]. Similar to STIM1, STIM2 also contains a Ca2+-binding cEF hand, a nEF hand, and a SAM domain. Despite lacking the Ca2+-binding site, the nEF-loop stabilizes the cEF-loop through hydrogen bonding between N(H) of Ile87 and C(O) of Ile119 to form EF-hand pairs. The tertiary structure of STIM2-EF-SAM is negatively charged at pH 7, which is mainly contributed by the amino acids present in the EF-hand pair. Like STIM1, the cEF-hand of STIM2 exists in an open conformation, which is measured by the interhelical angles, which are about > 80°. Because of this, STIM2 exposes large hydrophobic surfaces contributed by the following amino acids in the cEF-hand, namely Leu72, Ile75, His76, Met79, and Phe85. The amino acids from the nEF hand, such as Met100, Lys103, Lys108, Leu112, Ile119, Leu124, and Trp128, equally contribute to the hydrophobic patches. Together, the contribution of hydrophobic surfaces from the EF-hand motifs serves as a dock for its interaction with the hydrophobic regions of SAM [28].

4. Sterile Alpha Motif (SAM)

Sterile alpha motif, also known as SAM, is a well-conserved domain (~70 amino acids in length) that was first discovered in yeast proteins involved in differentiation from haploid to diploid cells [95,96,97]. It was later identified in many proteins from different kingdoms, such as in eukaryotes, bacteria, and viruses. Within the eukaryotes, SAM proteins have been found in mammals, such as humans, chimpanzees, rats, and mice, as well as in insects, fishes, frogs, worms, and birds. Recent SMART non-redundant database searches show that there are 64,647 SAM domains seen in 49,933 proteins, indicating that the SAM domain exists either as a single unit or in tandem repeats within a protein [98]. Interestingly, SAM domains are largely seen in multi-domain-containing proteins localized to different cellular compartments, indicating their diversified and extensive cellular functions [96].
The structural organization of the SAM domain consists of a five α-helix bundle where the α3 helix is shorter in length than the rest of the helices. SAM domains interact homomerically with each other or through heteromeric interactions with other proteins. Interestingly, both the homo and heterotypic interactions are guided through head-to-tail interactions, well known as the Mid-Loop (ML)/End-Helix (EH) model, wherein the middle portion of one SAM domain (ML surface) binds to the EH surface (c-terminal α5 helix and loop regions) of another SAM domain [99]. An example of the SAM heterotypic interactions through the ML/EH model is evident from the crystal structure of the Anks6-Sam/Anks3-Sam complex. The complex shows that the EH surface of the Anks3 protein interacts with the ML surface of the Anks6 protein [99,100]. On the other hand, neuronal scaffolding protein AIDA-1 contains two tandem SAM domains, which interact homomerically with each other through the ML/EH model (homotypic interaction). In addition to protein–protein interactions, SAM domains are also involved in SAM–lipid and SAM–RNA interactions, wherein they bind with other biological macromolecules with various stoichiometries [95,96,101].
As described in a recent review [99], aberrant SAM–SAM domain interactions may cause pathological cellular responses and conditions. For instance, the SAM domain of TEL mediates its oligomerization with various tyrosine kinases to induce constitutive activation that is essential for cell transformation and with transcription factors that result in the repression of gene transcription [102]. Axon degeneration is an evolutionarily conserved process that clears irreparably damaged axons following nerve injury and also enables developmental axon pruning. Aberrant regulation of axon degeneration leads to dysfunctional neuronal connectivity, as seen in neurodegenerative diseases and neuropathies. The sterile α-motif-containing and armadillo-motif-containing protein 1 (Sarm1) has a SAM domain that forms homotypic interactions. Mutating or deleting the Sarm1–SAM domain abolishes the Sarm1–Sarm1 interaction that is required for axonal degeneration [99,103]. Collectively, these studies suggested that signaling specificity by SAM–SAM domain interactions is mediated by distinct residues on their binding surfaces. The rest of the review will highlight what is currently known about the SAM domain of STIM proteins and their contribution to their physiological functions.

5. SAM Domain in STIM Proteins

In addition to the EF-hand domains, STIM proteins have one SAM domain: aa 132–200 in STIM1 and aa 136–204 in STIM2 [104]. In our survey of recent publications and protein databases, we found that STIMs are unique in this regard, as no other proteins contain both EF hand and SAM domains. Similar findings were reached by Stathopulos and colleagues [27]. Human STIM-SAM exhibits five a-helical structures, similar to those reported in other SAM domain-containing proteins [27,28,99]. Internal association of the STIM1 EF-hand hydrophobic cleft with the SAM domain was proposed to keep STIM1 in a compact structure, precluding non-specific interactions and solvent exposure of hydrophobic residues that could destabilize the protein [27]. For instance, to maintain STIM1 in a quiescent state, the C-terminal helix in STIM1-SAM (Leu195, Leu199) is anchored within the hydrophobic cleft of the EF hands (12 residues). Following store depletion, the EF-SAM of STIM1 unravels and oligomerizes to trigger conformational changes in the cytosolic C-terminus and subsequent translocation to the ER-PM junctions. Interestingly, the SAM domain of STIM1 is essential for its activation and puncta formation, as deleting the SAM domain results in continued STIM1 tracking along the microtubule following ER-Ca2+ store depletion [105]. In addition, recent studies indicate that amino acid substitutions in the α-7 and α-9 attenuate puncta formation and inhibit SAM multimerization and Orai1 channel activation [106].
Conversely, STIM2 is already partially activated in resting/unstimulated cells, regardless of its higher stability (EF-SAM) than STIM1. The stability of the STIM2-EF-SAM was enhanced by a more extensive hydrophobic cleft (12 residues) in the EF-hands and hydrophobic core (12 residues) in the SAM domain. Additionally, ionic interactions between the Lys103 and Asp200 further stabilize STIM2-EF-SAM [28,104]. Interestingly, while STIM2-EF-SAM is more stable than STIM1-EF-SAM, STIM2-SAM has the lowest oligomerization tendency, while STIM1-SAM shows the greatest tendency. STIM1-EF-SAM exists as a monomer in the presence of Ca2+ but forms multimers in its absence. In addition to the stability, EF-SAM of STIM proteins differs in their interhelical angles between cEF-hand (α2 helix) and SAM domain (α10 helix). At the same time, STIM2 adopts a parallel orientation, while STIM1 has a perpendicular orientation. It is interesting to note that STIM from C. elegans adopts a similar parallel orientation as STIM2 [107]. The differing cEF-hand-SAM conformations likely influence STIM-SAM domain interactions. Moreover, given the greater STIM2-EF-SAM stability, fractional changes in STIM2 structure may be sufficient to affect its function [108].
An early screen for human SAM (hSAM) domains for polymerization identified several SAM domain-containing proteins in the SMART and NCBI gene databases. A total of 114 unique hSAM domains were identified from 92 proteins in the human genome. Of these, 96 unique hSAM domains from 77 proteins were fused with the super-negatively charged green fluorescent protein (neg-GFP) to analyze their polymerization potential. Interestingly, STIM2 was identified as an hSAM domain that appears to form well-organized polymers instead of simple amorphous aggregates [109]. It is not known why STIM1 was not identified on the same screen, but one possible explanation could be its lower protein expression. STIM proteins were proposed to have evolved to differentially regulate Orai channels through a divergent balance between the Ca2+ binding affinity of cEF-hand and SAM domain stability or oligomerization tendency. STIM1-SAM instability and weakly structured Ca2+-free EF-SAM enhance STIM1/Orai1 interaction following store depletion. In contrast, STIM2 is more stable and compact under these conditions, which increases the time required for maximal Orai1 channel activation [28]. Combined with the ability of STIM2 cEF-hand to sense smaller changes in [Ca2+]ER, pre-clustering of STIM2 in ER-PM junctions enables STIM2 to more readily gate Orai1 following cell stimulation. Additionally, STIM2 can also recruit STIM1 into the same ER-PM junctions to enhance Orai1 channel gating, especially with relatively low physiological agonist stimulation [45]. The ability of STIM proteins to form homomers and heteromers enables the cells to tune the response to variable stimuli. However, the role of SAM domains in the STIM2-STIM1 interaction or STIM2 dimerization is yet to be understood.

6. Naturally Occurring Mutations in STIM Proteins and Disease

Studies reported over the past several years have revealed significant pathological consequences of mutations in STIM1 that lead to aberrant function. It is important to note that disease-associated mutations in both N- and C-terminal domains have been described only for STIM1 but not for STIM2. A change in the expression level of the STIM2 protein or a modification of the protein that causes functional changes has been reported under certain pathological conditions, and these might contribute to the severity of the condition. Here, we will discuss the mutations in the N-terminal domain of STIM1. Several gain of function (GoF) mutations have been described in the N-termini of STIM1, which cause Tubular aggregate myopathy (TAM) (Figure 3). Of these, five mutations are located in the cEF-hand (Figure 3a), and the remaining is in the nEF-hand [18,110,111,112,113]. H72Q and L96V are located in the E and F helices, respectively, of the cEF-hand. While the STIM1-H72Q mutant exhibits constitutive puncta formation, no clinical symptoms have been reported so far [111]. Although the H72Q mutation does not affect the Ca2+-coordinating residues involved in direct Ca2+-binding in the cEF loop, it may be involved in stabilizing the intramolecular interactions favoring compactness of STIM1 luminal structure in cooperation with the SAM domain [27,89]. Asn at the 5th position in the cEF loop is important as it directly coordinates Ca2+. An Asn to Thr (N80T) mutation has been shown to cause significant STIM1 clustering without store depletion, and the patients exhibit symptoms such as myalgia and high creatinine kinase levels [110]. The other two mutations are at the 6th (G81D) and 9th (D84G) in the cEF loop of STIM1. Studies suggest that both G81D and D84G cause constitutive Ca2+ entry and increase in SOCE. In addition, the D84G mutant also exhibits bleeding disorder and malfunctioning of platelets in mice [18,114,115].
Among the nEF-hand mutants, F108I/L, H109N/R/Y, and I115F are located in the loop connecting the two helices at the 1st, 2nd, and 8th positions, respectively (Figure 3b). It is interesting to note that the I115F mutation is seen in patients of both TAM and York platelet syndrome. Mutation of F108 to either Leu (L) or Ile (I) causes proximal muscle weakness and adult-onset myalgia, respectively [110,111]. Sallinger et al. reported that these loop mutants (F108I, H109N/R, and I115F) exhibit high cytosolic Ca2+ levels in the absence of stimulus, constitutive activation of STIM1, active Ca2+ entry, and increased NFAT nuclear translocation [89,110,111,116]. Biophysical studies such as far-UV CD spectra of F108I indicate a similar α-helical structure as that of wild-type STIM1. However, the F108I mutation destabilizes the protein by affecting its Ca2+-binding affinity and overall stability. Of note, STIM1-F108I binds Ca2+ with a comparatively weaker affinity and is less thermostable than the wild-type STIM1. Molecular dynamics simulation studies also indicate that the F108I mutation destabilizes the hydrophobic cleft following the unfolding of the nEF hand, whereas the cEF-hand and SAM domain remain stable [89].
In addition to the EF-hand mutations, several studies have reported STIM1-SAM mutations that caused impaired protein function and disease. One study analyzed 37 STIM1 variants found in three pancreatitis patient cohorts, 5 of which are in the SAM domain (E136D, E152K, T153I, Q158E, and T177I). The p.E152K variant is extremely rare in the general population (observed in only three patients) and affects a highly conserved amino acid located in the α2 helix of the SAM domain. HEK293 cells expressing STIM1-E152K showed greater ER-Ca2+ store release when stimulated with thapsigargin, tBHQ, and carbachol, resulting in higher Ca2+ influx with re-addition of CaCl2. The three patients with the STIM1 p.E152K variant also had heterozygous variants of other chronic pancreatitis susceptibility genes (e.g., PRSS1 p.P365R, a rare variant). Fibroblasts isolated from a patient with STIM1 p.E152K and PRSS1 p.P365R showed enhanced rate and magnitude of Ca2+ store release and SOCE. Similar results were obtained when STIM1-E125K was expressed in rat pancreatic AR42J cells following stimulation with cholecystokinin, carbachol, and thapsigargin. AR42J cells expressing STIM1-E152K also showed higher levels of activated trypsin and cell toxicity in unstimulated cells, with further increases following stimulation with cholecystokinin. Mutating the conserved Glu (E152) to Lys (K) destabilizes the Ca2+-bound EF-SAM but stabilizes the Ca2+-free structure. STIM1-E152K displayed enhanced aggregation due to the destabilized Ca2+-bound EF-SAM transitions more readily to form aggregates, and/or the Ca2+-free EF-SAM exhibits greater stability following multimerization. The authors proposed that STIM1-E152K interacts with the SERCA pump to modulate its activity and enhance ER re-filling, which may account for the enhanced ER-Ca2+ release due to higher [Ca2+]ER [117].
STIM1-P165Q is another SAM domain mutation first identified in two siblings who harbor a novel homozygous missense mutation c.C494A in exon 4. PBMCs and PHA-induced T cells obtained from one sibling exhibited decreased SOCE and reduced STIM1 protein expression [118]. Activation was adversely affected by impaired dimer formation of STIM1-P165Q [108]. Another variation within the STIM1-SAM domain, V138I, leads to constitutively higher basal [Ca2+]i and enhanced SOCE in HEK293 cells expressing STIM1-V138I. This STIM1-SAM mutant was discovered in a cross-sectional study of patients harboring monoallelic STIM1 variants and exhibiting musculature disorders [108,119]. STIM1-E136X is a unique mutation where an adenine insertion in exon 3 produced a scrambled sequence of 8 amino acids and a premature stop codon (c.f. wild type STIM1), resulting in undetectable protein levels in affected patients. Interestingly, STIM1-E136X was also identified in Stormorken syndrome patients, who harbor a gain of function mutation in the STIM1 C-terminus. The STIM1-SAM domains also contain several glycosylation sites that control STIM1 function. A double mutant, STIM1-N131D-N171Q, leads to a gain of function effect that allows faster gating of the Orai1 channel. Further studies are required to evaluate how these STIM1-SAM domain mutations affect protein structure and behavior in order to explain their effects on STIM1 function [108].
Unlike STIM1, there is no clear evidence of pathophysiological conditions in humans caused by single nucleotide mutations in STIM2. Although the Clinvar database (https://www.ncbi.nlm.nih.gov/clinvar/?term=STIM2[sym]) (URL (accessed on 5th May 2024) [120] reports several missense variants in 3′UTR and protein-coding regions of STIM2, including the cEF-, nEF-, and SAM domain, the clinical significance of these variants is currently unknown. As these variants have been reported recently, it would be interesting to see future studies evaluating their functional effects and clinical symptoms. Thus, no single nucleotide mutations linked to diseases have been reported for STIM2 so far. Conversely, several studies have elucidated the probable role of STIM2 in pathological conditions related to neurodegenerative diseases, immune function, cancer, etc., which are extensively reviewed in [114,121]. In addition, several studies report abnormal phenotypes in patients having either proximal interstitial deletion [122,123], translocation [124], or duplication [125] in the short arm of chromosome 4 near the STIM2 gene (p15.2). The most common phenotypes observed in those younger patients are physical and facial anomalies, intellectual disability, developmental delay, neurological dysfunction, and congenital heart diseases [114,121,122,123,124,125]. Since multiple genes are involved in those chromosome alterations, it is very difficult to delineate the contribution of STIM2 in those phenotypes. More studies should be focused on understanding the pathological phenotypes associated with the STIM2 gene alterations.

7. Conclusions

STIM1 and STIM2 are unique bi-functional proteins that serve as sensors of [Ca2+] in the ER lumen and activators of the Orai Ca2+ channels in the plasma membrane. Their structure and regulation allow them to sense changes in ER-[Ca2+] and transmit the signal to the plasma membrane channel to trigger Ca2+ entry. This mechanism, referred to as store-operated calcium entry, is ubiquitously present in all cell types and involves activation of Ca2+ influx into cells via Orai channels in response to agonist-stimulated decreases in ER-[Ca2+]. The evolution and distinct functional characteristics speak to the unique function of each protein. STIM2 and STIM1 display high and low Ca2+ affinities that permit them to differentially sense minor or major decreases in ER-Ca2+, respectively. Further, they also differ in their activation of Orai1, with STIM1 exerting a stronger activation of Ca2+ entry than STIM2. These specific properties lead to the tuning of Orai1 activity over a wide range of stimulus intensities. The STIMs have a Ca2+-sensing N-terminus, which resides in the ER lumen, a single transmembrane domain that spans the ER membrane, and a C-terminal domain that is located in the cytosol. The N-terminus has a Ca2+-binding canonical EF-hand domain, a non-canonical EF-hand domain, and a SAM domain, while the C-terminus has several coiled-coil domains, which include an Orai-binding/activation region (SOAR) and a polybasic tail that binds to plasma membrane lipids. Unbinding of Ca2+ from the EF-hand domain is suggested to induce conformational changes in the N-terminus that are then propagated to the C-terminus, causing the SOAR domain to be exposed and the C-terminal poly-basic motif to scaffold to the plasma membrane. Relatively more studies have been carried out with the STIM1 C-terminus than its N-terminus. NMR studies have elaborated the N-terminal structure of STIM proteins, but detailed structure–function analysis is yet lacking. Further studies are required to determine the contributions of non-canonical and SAM domains to the Ca2+ sensing and regulation of the protein. Recently, MD-simulation approaches have provided insights into the conformational dynamics of STIM1 N-terminus during Ca2+ sensing and activation. However, a lot more data are required to clarify the same for STIM2. In particular, very little is understood regarding the conformational changes in the STIM2-N terminus in response to Ca2+. More importantly, there are sparse structural data on the C-terminus of both STIM1 and STIM2. As more mutations related to human diseases are identified for STIM1 and STIM2, it will be necessary to understand the structure–function relationships of the various functional domains of these proteins so that knowledge-based targeting can be utilized for therapies.

Author Contributions

S.N., H.L.O. and I.S.A. wrote and edited the manuscript. I.S.A. also supervised the manuscript preparation. All authors have read and agreed to the published version of the manuscript.

Funding

Funding for this work was provided by NIDCR-DIR, NIH (Z01-DE00438-35) for I.S.A.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Carafoli, E.; Krebs, J. Why Calcium? How Calcium Became the Best Communicator. J. Biol. Chem. 2016, 291, 20849–20857. [Google Scholar] [CrossRef]
  2. Berridge, M.J.; Lipp, P.; Bootman, M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1, 11–21. [Google Scholar] [CrossRef] [PubMed]
  3. Berridge, M.J.; Bootman, M.D.; Lipp, P. Calcium—A life and death signal. Nature 1998, 395, 645–648. [Google Scholar] [CrossRef] [PubMed]
  4. Berridge, M.J. Neuronal calcium signaling. Neuron 1998, 21, 13–26. [Google Scholar] [CrossRef] [PubMed]
  5. Cai, X.; Wang, X.; Patel, S.; Clapham, D.E. Insights into the early evolution of animal calcium signaling machinery: A unicellular point of view. Cell Calcium 2015, 57, 166–173. [Google Scholar] [CrossRef] [PubMed]
  6. Clapham, D.E. Calcium signaling. Cell 1995, 80, 259–268. [Google Scholar] [CrossRef] [PubMed]
  7. Hirschi, K.D. The calcium conundrum. Both versatile nutrient and specific signal. Plant Physiol. 2004, 136, 2438–2442. [Google Scholar] [CrossRef]
  8. Plattner, H.; Verkhratsky, A. The ancient roots of calcium signalling evolutionary tree. Cell Calcium 2015, 57, 123–132. [Google Scholar] [CrossRef]
  9. Berridge, M.J. Elementary and global aspects of calcium signalling. J. Physiol. 1997, 499 Pt 2, 291–306. [Google Scholar] [CrossRef]
  10. Trump, B.F.; Berezesky, I.K. Calcium-mediated cell injury and cell death. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 1995, 9, 219–228. [Google Scholar] [CrossRef]
  11. Pchitskaya, E.; Popugaeva, E.; Bezprozvanny, I. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 2018, 70, 87–94. [Google Scholar] [CrossRef] [PubMed]
  12. Collins, S.R.; Meyer, T. Evolutionary origins of STIM1 and STIM2 within ancient Ca2+ signaling systems. Trends Cell Biol. 2011, 21, 202–211. [Google Scholar] [CrossRef] [PubMed]
  13. Bootman, M.D.; Berridge, M.J. The elemental principles of calcium signaling. Cell 1995, 83, 675–678. [Google Scholar] [CrossRef] [PubMed]
  14. Bootman, M.D.; Bultynck, G. Fundamentals of Cellular Calcium Signaling: A Primer. Cold Spring Harb. Perspect. Biol. 2020, 12, a038802. [Google Scholar] [CrossRef] [PubMed]
  15. Hiraoki, T.; Vogel, H.J. Structure and function of calcium-binding proteins. J. Cardiovasc. Pharmacol. 1987, 10 (Suppl. S1), S14–S31. [Google Scholar] [CrossRef]
  16. Herzberg, O.; Moult, J.; James, M.N. A model for the Ca2+-induced conformational transition of troponin C. A trigger for muscle contraction. J. Biol. Chem. 1986, 261, 2638–2644. [Google Scholar] [CrossRef]
  17. Prakriya, M.; Lewis, R.S. Store-Operated Calcium Channels. Physiol. Rev. 2015, 95, 1383–1436. [Google Scholar] [CrossRef]
  18. Lacruz, R.S.; Feske, S. Diseases caused by mutations in ORAI1 and STIM1. Ann. N. Y Acad. Sci. 2015, 1356, 45–79. [Google Scholar] [CrossRef]
  19. Putney, J.W., Jr. A model for receptor-regulated calcium entry. Cell Calcium 1986, 7, 1–12. [Google Scholar] [CrossRef]
  20. Xie, J.; Pan, H.; Yao, J.; Zhou, Y.; Han, W. SOCE and cancer: Recent progress and new perspectives. Int. J. Cancer 2016, 138, 2067–2077. [Google Scholar] [CrossRef]
  21. Lewis, R.S. The molecular choreography of a store-operated calcium channel. Nature 2007, 446, 284–287. [Google Scholar] [CrossRef] [PubMed]
  22. Hogan, P.G.; Lewis, R.S.; Rao, A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 2010, 28, 491–533. [Google Scholar] [CrossRef] [PubMed]
  23. Lewis, R.S. Store-operated calcium channels: New perspectives on mechanism and function. Cold Spring Harb. Perspect. Biol. 2011, 3, a003970. [Google Scholar] [CrossRef]
  24. Gudlur, A.; Zhou, Y.; Hogan, P.G. STIM-ORAI interactions that control the CRAC channel. Curr. Top. Membr. 2013, 71, 33–58. [Google Scholar] [CrossRef] [PubMed]
  25. Lewis, R.S. Store-Operated Calcium Channels: From Function to Structure and Back Again. Cold Spring Harb. Perspect. Biol. 2020, 12, a035055. [Google Scholar] [CrossRef] [PubMed]
  26. Ong, H.L.; de Souza, L.B.; Zheng, C.; Cheng, K.T.; Liu, X.; Goldsmith, C.M.; Feske, S.; Ambudkar, I.S. STIM2 enhances receptor-stimulated Ca2+ signaling by promoting recruitment of STIM1 to the endoplasmic reticulum-plasma membrane junctions. Sci. Signal 2015, 8, ra3. [Google Scholar] [CrossRef]
  27. Stathopulos, P.B.; Zheng, L.; Li, G.Y.; Plevin, M.J.; Ikura, M. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell 2008, 135, 110–122. [Google Scholar] [CrossRef]
  28. Zheng, L.; Stathopulos, P.B.; Schindl, R.; Li, G.Y.; Romanin, C.; Ikura, M. Auto-inhibitory role of the EF-SAM domain of STIM proteins in store-operated calcium entry. Proc. Natl. Acad. Sci. USA 2011, 108, 1337–1342. [Google Scholar] [CrossRef]
  29. Cai, X. Molecular evolution and structural analysis of the Ca2+ release-activated Ca2+ channel subunit, Orai. J. Mol. Biol. 2007, 368, 1284–1291. [Google Scholar] [CrossRef]
  30. Feske, S.; Gwack, Y.; Prakriya, M.; Srikanth, S.; Puppel, S.H.; Tanasa, B.; Hogan, P.G.; Lewis, R.S.; Daly, M.; Rao, A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441, 179–185. [Google Scholar] [CrossRef]
  31. Vig, M.; Peinelt, C.; Beck, A.; Koomoa, D.L.; Rabah, D.; Koblan-Huberson, M.; Kraft, S.; Turner, H.; Fleig, A.; Penner, R.; et al. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 2006, 312, 1220–1223. [Google Scholar] [CrossRef] [PubMed]
  32. Zhang, S.L.; Yeromin, A.V.; Zhang, X.H.; Yu, Y.; Safrina, O.; Penna, A.; Roos, J.; Stauderman, K.A.; Cahalan, M.D. Genome-wide RNAi screen of Ca2+ influx identifies genes that regulate Ca2+ release-activated Ca2+ channel activity. Proc. Natl. Acad. Sci. USA 2006, 103, 9357–9362. [Google Scholar] [CrossRef] [PubMed]
  33. Jardin, I.; Berna-Erro, A.; Nieto-Felipe, J.; Macias, A.; Sanchez-Collado, J.; Lopez, J.J.; Salido, G.M.; Rosado, J.A. Similarities and Differences between the Orai1 Variants: Orai1α and Orai1β. Int. J. Mol. Sci. 2022, 23, 14568. [Google Scholar] [CrossRef] [PubMed]
  34. Trebak, M.; Putney, J.W., Jr. ORAI Calcium Channels. Physiology 2017, 32, 332–342. [Google Scholar] [CrossRef]
  35. Frischauf, I.; Schindl, R.; Bergsmann, J.; Derler, I.; Fahrner, M.; Muik, M.; Fritsch, R.; Lackner, B.; Groschner, K.; Romanin, C. Cooperativeness of Orai cytosolic domains tunes subtype-specific gating. J. Biol. Chem. 2011, 286, 8577–8584. [Google Scholar] [CrossRef]
  36. Fukushima, M.; Tomita, T.; Janoshazi, A.; Putney, J.W. Alternative translation initiation gives rise to two isoforms of Orai1 with distinct plasma membrane mobilities. J. Cell Sci. 2012, 125, 4354–4361. [Google Scholar] [CrossRef]
  37. Desai, P.N.; Zhang, X.; Wu, S.; Janoshazi, A.; Bolimuntha, S.; Putney, J.W.; Trebak, M. Multiple types of calcium channels arising from alternative translation initiation of the Orai1 message. Sci. Signal 2015, 8, ra74. [Google Scholar] [CrossRef]
  38. Luik, R.M.; Wu, M.M.; Buchanan, J.; Lewis, R.S. The elementary unit of store-operated Ca2+ entry: Local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J. Cell Biol. 2006, 174, 815–825. [Google Scholar] [CrossRef]
  39. Soboloff, J.; Spassova, M.A.; Tang, X.D.; Hewavitharana, T.; Xu, W.; Gill, D.L. Orai1 and STIM reconstitute store-operated calcium channel function. J. Biol. Chem. 2006, 281, 20661–20665. [Google Scholar] [CrossRef]
  40. Peinelt, C.; Vig, M.; Koomoa, D.L.; Beck, A.; Nadler, M.J.; Koblan-Huberson, M.; Lis, A.; Fleig, A.; Penner, R.; Kinet, J.P. Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat. Cell Biol. 2006, 8, 771–773. [Google Scholar] [CrossRef]
  41. Huang, G.N.; Zeng, W.; Kim, J.Y.; Yuan, J.P.; Han, L.; Muallem, S.; Worley, P.F. STIM1 carboxyl-terminus activates native SOC, Icrac and TRPC1 channels. Nat. Cell Biol. 2006, 8, 1003–1010. [Google Scholar] [CrossRef] [PubMed]
  42. Roos, J.; DiGregorio, P.J.; Yeromin, A.V.; Ohlsen, K.; Lioudyno, M.; Zhang, S.; Safrina, O.; Kozak, J.A.; Wagner, S.L.; Cahalan, M.D.; et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J. Cell Biol. 2005, 169, 435–445. [Google Scholar] [CrossRef] [PubMed]
  43. Liou, J.; Kim, M.L.; Heo, W.D.; Jones, J.T.; Myers, J.W.; Ferrell, J.E., Jr.; Meyer, T. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr. Biol. 2005, 15, 1235–1241. [Google Scholar] [CrossRef] [PubMed]
  44. Brandman, O.; Liou, J.; Park, W.S.; Meyer, T. STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 2007, 131, 1327–1339. [Google Scholar] [CrossRef]
  45. Subedi, K.P.; Ong, H.L.; Son, G.Y.; Liu, X.; Ambudkar, I.S. STIM2 Induces Activated Conformation of STIM1 to Control Orai1 Function in ER-PM Junctions. Cell Rep. 2018, 23, 522–534. [Google Scholar] [CrossRef]
  46. Wang, X.; Wang, Y.; Zhou, Y.; Hendron, E.; Mancarella, S.; Andrake, M.D.; Rothberg, B.S.; Soboloff, J.; Gill, D.L. Distinct Orai-coupling domains in STIM1 and STIM2 define the Orai-activating site. Nat. Commun. 2014, 5, 3183. [Google Scholar] [CrossRef]
  47. Ahmad, M.; Ong, H.L.; Saadi, H.; Son, G.Y.; Shokatian, Z.; Terry, L.E.; Trebak, M.; Yule, D.I.; Ambudkar, I. Functional communication between IP3R and STIM2 at subthreshold stimuli is a critical checkpoint for initiation of SOCE. Proc. Natl. Acad. Sci. USA 2022, 119, e2114928118. [Google Scholar] [CrossRef]
  48. Kretsinger, R.H.; Nockolds, C.E. Carp muscle calcium-binding protein. II. Structure determination and general description. J. Biol. Chem. 1973, 248, 3313–3326. [Google Scholar] [CrossRef]
  49. Kawasaki, H.; Kretsinger, R.H. Structural and functional diversity of EF-hand proteins: Evolutionary perspectives. Protein Sci. 2017, 26, 1898–1920. [Google Scholar] [CrossRef]
  50. Grabarek, Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J. Mol. Biol. 2006, 359, 509–525. [Google Scholar] [CrossRef]
  51. Babu, Y.S.; Sack, J.S.; Greenhough, T.J.; Bugg, C.E.; Means, A.R.; Cook, W.J. Three-dimensional structure of calmodulin. Nature 1985, 315, 37–40. [Google Scholar] [CrossRef] [PubMed]
  52. Shaw, G.S.; Hodges, R.S.; Sykes, B.D. Calcium-induced peptide association to form an intact protein domain: 1H NMR structural evidence. Science 1990, 249, 280–283. [Google Scholar] [CrossRef] [PubMed]
  53. Jung, D.H.; Mo, S.H.; Kim, D.H. Calumenin, a multiple EF-hands Ca2+-binding protein, interacts with ryanodine receptor-1 in rabbit skeletal sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 2006, 343, 34–42. [Google Scholar] [CrossRef] [PubMed]
  54. Apic, G.; Gough, J.; Teichmann, S.A. Domain combinations in archaeal, eubacterial and eukaryotic proteomes. J. Mol. Biol. 2001, 310, 311–325. [Google Scholar] [CrossRef] [PubMed]
  55. Petri, E.T.; Celic, A.; Kennedy, S.D.; Ehrlich, B.E.; Boggon, T.J.; Hodsdon, M.E. Structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity. Proc. Natl. Acad. Sci. USA 2010, 107, 9176–9181. [Google Scholar] [CrossRef]
  56. Sorimachi, H.; Hata, S.; Ono, Y. Calpain chronicle--an enzyme family under multidisciplinary characterization. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2011, 87, 287–327. [Google Scholar] [CrossRef]
  57. de Alba, E.; Tjandra, N. Structural studies on the Ca2+-binding domain of human nucleobindin (calnuc). Biochemistry 2004, 43, 10039–10049. [Google Scholar] [CrossRef]
  58. Shaw, G.S.; Findlay, W.A.; Semchuk, P.D.; Hodges, R.S.; Sykes, B.D. Specific formation of a heterodimeric two-site calcium-binding domain from synthetic peptides. J. Am. Chem. Soc. 1992, 114, 6258–6259. [Google Scholar] [CrossRef]
  59. Linse, S.; Thulin, E.; Sellers, P. Disulfide bonds in homo- and heterodimers of EF-hand subdomains of calbindin D9k: Stability, calcium binding, and NMR studies. Protein Sci. 1993, 2, 985–1000. [Google Scholar] [CrossRef]
  60. Durussel, I.; Luan-Rilliet, Y.; Petrova, T.; Takagi, T.; Cox, J.A. Cation binding and conformation of tryptic fragments of Nereis sarcoplasmic calcium-binding protein: Calcium-induced homo- and heterodimerization. Biochemistry 1993, 32, 2394–2400. [Google Scholar] [CrossRef]
  61. Nelson, M.R.; Chazin, W.J. Structures of EF-hand Ca2+-binding proteins: Diversity in the organization, packing and response to Ca2+ binding. Biometals 1998, 11, 297–318. [Google Scholar] [CrossRef] [PubMed]
  62. Strynadka, N.C.; James, M.N. Crystal structures of the helix-loop-helix calcium-binding proteins. Annu. Rev. Biochem. 1989, 58, 951–998. [Google Scholar] [CrossRef] [PubMed]
  63. Gifford, J.L.; Walsh, M.P.; Vogel, H.J. Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs. Biochem. J. 2007, 405, 199–221. [Google Scholar] [CrossRef] [PubMed]
  64. Reid, R.E. Synthetic fragments of calmodulin calcium-binding site III. A test of the acid pair hypothesis. J. Biol. Chem. 1990, 265, 5971–5976. [Google Scholar] [CrossRef]
  65. Lewit-Bentley, A.; Rety, S. EF-hand calcium-binding proteins. Curr. Opin. Struct. Biol. 2000, 10, 637–643. [Google Scholar] [CrossRef]
  66. Declercq, J.P.; Tinant, B.; Parello, J.; Rambaud, J. Ionic interactions with parvalbumins. Crystal structure determination of pike 4.10 parvalbumin in four different ionic environments. J. Mol. Biol. 1991, 220, 1017–1039. [Google Scholar] [CrossRef]
  67. Houdusse, A.; Cohen, C. Structure of the regulatory domain of scallop myosin at 2 A resolution: Implications for regulation. Structure 1996, 4, 21–32. [Google Scholar] [CrossRef]
  68. Malmendal, A.; Linse, S.; Evenas, J.; Forsen, S.; Drakenberg, T. Battle for the EF-hands: Magnesium-calcium interference in calmodulin. Biochemistry 1999, 38, 11844–11850. [Google Scholar] [CrossRef]
  69. Grabarek, Z. Insights into modulation of calcium signaling by magnesium in calmodulin, troponin C and related EF-hand proteins. Biochim. Biophys. Acta 2011, 1813, 913–921. [Google Scholar] [CrossRef]
  70. Chin, D.; Means, A.R. Calmodulin: A prototypical calcium sensor. Trends Cell Biol. 2000, 10, 322–328. [Google Scholar] [CrossRef]
  71. Nishio, T.; Iio, T. Static and kinetic studies on rabbit skeletal muscle troponin. J. Biochem. 1983, 94, 745–754. [Google Scholar] [CrossRef] [PubMed]
  72. Chen, H.; Xu, C.; Jin, Q.; Liu, Z. S100 protein family in human cancer. Am. J. Cancer Res. 2014, 4, 89–115. [Google Scholar] [PubMed]
  73. Schwaller, B. Emerging Functions of the “Ca2+ Buffers” Parvalbumin, Calbindin D-28k and Calretinin in the Brain. In Handbook of Neurochemistry and Molecular Neurobiology: Neural Protein Metabolism and Function; Lajtha, A., Banik, N., Eds.; Springer: Boston, MA, USA, 2007; pp. 197–221. [Google Scholar]
  74. Krebs, J.; Michalak, M. Calcium: A Matter of Life or Death; Elsevier: Amsterdam, The Netherlands, 2007. [Google Scholar]
  75. Schwaller, B. Cytosolic Ca2+ buffers. Cold Spring Harb. Perspect. Biol. 2010, 2, a004051. [Google Scholar] [CrossRef] [PubMed]
  76. Falke, J.J.; Drake, S.K.; Hazard, A.L.; Peersen, O.B. Molecular tuning of ion binding to calcium signaling proteins. Q. Rev. Biophys. 1994, 27, 219–290. [Google Scholar] [CrossRef]
  77. Allen, M.D.; Qamar, S.; Vadivelu, M.K.; Sandford, R.N.; Bycroft, M. A high-resolution structure of the EF-hand domain of human polycystin-2. Protein Sci. 2014, 23, 1301–1308. [Google Scholar] [CrossRef]
  78. Narayanasamy, S.; Aradhyam, G.K. The Differential Response to Ca2+ from Vertebrate and Invertebrate Calumenin is Governed by a Single Amino Acid Residue. Biochemistry 2018, 57, 722–731. [Google Scholar] [CrossRef]
  79. Cook, W.J.; Jeffrey, L.C.; Cox, J.A.; Vijay-Kumar, S. Structure of a sarcoplasmic calcium-binding protein from amphioxus refined at 2.4 A resolution. J. Mol. Biol. 1993, 229, 461–471. [Google Scholar] [CrossRef]
  80. Gentry, H.R.; Singer, A.U.; Betts, L.; Yang, C.; Ferrara, J.D.; Sondek, J.; Parise, L.V. Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins. J. Biol. Chem. 2005, 280, 8407–8415. [Google Scholar] [CrossRef]
  81. Vijay-Kumar, S.; Cook, W.J. Structure of a sarcoplasmic calcium-binding protein from Nereis diversicolor refined at 2.0 A resolution. J. Mol. Biol. 1992, 224, 413–426. [Google Scholar] [CrossRef]
  82. Jia, J.; Tarabykina, S.; Hansen, C.; Berchtold, M.; Cygler, M. Structure of apoptosis-linked protein ALG-2: Insights into Ca2+-induced changes in penta-EF-hand proteins. Structure 2001, 9, 267–275. [Google Scholar] [CrossRef]
  83. Blanchard, H.; Grochulski, P.; Li, Y.; Arthur, J.S.; Davies, P.L.; Elce, J.S.; Cygler, M. Structure of a calpain Ca2+-binding domain reveals a novel EF-hand and Ca2+-induced conformational changes. Nat. Struct. Biol. 1997, 4, 532–538. [Google Scholar] [CrossRef] [PubMed]
  84. Zheng, L.; Stathopulos, P.B.; Li, G.Y.; Ikura, M. Biophysical characterization of the EF-hand and SAM domain containing Ca2+ sensory region of STIM1 and STIM2. Biochem. Biophys. Res. Commun. 2008, 369, 240–246. [Google Scholar] [CrossRef] [PubMed]
  85. Halder, R.; Warshel, A. Energetic and structural insights behind calcium induced conformational transition in calmodulin. Proteins 2023, 92, 384–394. [Google Scholar] [CrossRef]
  86. Suarez, M.C.; Rocha, C.B.; Sorenson, M.M.; Silva, J.L.; Foguel, D. Free-energy linkage between folding and calcium binding in EF-hand proteins. Biophys. J. 2008, 95, 4820–4828. [Google Scholar] [CrossRef] [PubMed]
  87. Stathopulos, P.B.; Li, G.Y.; Plevin, M.J.; Ames, J.B.; Ikura, M. Stored Ca2+ depletion-induced oligomerization of stromal interaction molecule 1 (STIM1) via the EF-SAM region: An initiation mechanism for capacitive Ca2+ entry. J. Biol. Chem. 2006, 281, 35855–35862. [Google Scholar] [CrossRef]
  88. Gudlur, A.; Zeraik, A.E.; Hirve, N.; Rajanikanth, V.; Bobkov, A.A.; Ma, G.; Zheng, S.; Wang, Y.; Zhou, Y.; Komives, E.A.; et al. Calcium sensing by the STIM1 ER-luminal domain. Nat. Commun. 2018, 9, 4536. [Google Scholar] [CrossRef]
  89. Schober, R.; Bonhenry, D.; Lunz, V.; Zhu, J.; Krizova, A.; Frischauf, I.; Fahrner, M.; Zhang, M.; Waldherr, L.; Schmidt, T.; et al. Sequential activation of STIM1 links Ca2+ with luminal domain unfolding. Sci. Signal 2019, 12, eaax3194. [Google Scholar] [CrossRef]
  90. Ikura, M.; Minowa, O.; Hikichi, K. Hydrogen bonding in the carboxyl-terminal half-fragment 78-148 of calmodulin as studied by two-dimensional nuclear magnetic resonance. Biochemistry 1985, 24, 4264–4269. [Google Scholar] [CrossRef]
  91. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215, 403–410. [Google Scholar] [CrossRef]
  92. UniProt, C. UniProt: The Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023, 51, D523–D531. [Google Scholar] [CrossRef]
  93. Rozewicki, J.; Li, S.; Amada, K.M.; Standley, D.M.; Katoh, K. MAFFT-DASH: Integrated protein sequence and structural alignment. Nucleic Acids Res. 2019, 47, W5–W10. [Google Scholar] [CrossRef] [PubMed]
  94. Cai, X. Molecular evolution and functional divergence of the Ca2+ sensor protein in store-operated Ca2+ entry: Stromal interaction molecule. PLoS ONE 2007, 2, e609. [Google Scholar] [CrossRef] [PubMed]
  95. Kim, C.A.; Bowie, J.U. SAM domains: Uniform structure, diversity of function. Trends Biochem. Sci. 2003, 28, 625–628. [Google Scholar] [CrossRef] [PubMed]
  96. Qiao, F.; Bowie, J.U. The many faces of SAM. Sci. STKE 2005, 2005, re7. [Google Scholar] [CrossRef] [PubMed]
  97. Schultz, J.; Ponting, C.P.; Hofmann, K.; Bork, P. SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 1997, 6, 249–253. [Google Scholar] [CrossRef]
  98. SMART. (A Simple Modular Architecture Research Tool): SAM Domain Annotation. Available online: https://smart.embl.de/smart/do_annotation.pl?DOMAIN=SM00454 (accessed on 7 December 2023).
  99. Vincenzi, M.; Mercurio, F.A.; Leone, M. Sam Domains in Multiple Diseases. Curr. Med. Chem. 2020, 27, 450–476. [Google Scholar] [CrossRef]
  100. Leettola, C.N.; Knight, M.J.; Cascio, D.; Hoffman, S.; Bowie, J.U. Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3. BMC Struct. Biol. 2014, 14, 17. [Google Scholar] [CrossRef]
  101. Stafford, R.L.; Hinde, E.; Knight, M.J.; Pennella, M.A.; Ear, J.; Digman, M.A.; Gratton, E.; Bowie, J.U. Tandem SAM domain structure of human Caskin1: A presynaptic, self-assembling scaffold for CASK. Structure 2011, 19, 1826–1836. [Google Scholar] [CrossRef]
  102. Kim, C.A.; Phillips, M.L.; Kim, W.; Gingery, M.; Tran, H.H.; Robinson, M.A.; Faham, S.; Bowie, J.U. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression. EMBO J. 2001, 20, 4173–4182. [Google Scholar] [CrossRef]
  103. Gerdts, J.; Summers, D.W.; Sasaki, Y.; DiAntonio, A.; Milbrandt, J. Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J. Neurosci. 2013, 33, 13569–13580. [Google Scholar] [CrossRef]
  104. Stathopulos, P.B.; Ikura, M. Structural aspects of calcium-release activated calcium channel function. Channels 2013, 7, 344–353. [Google Scholar] [CrossRef] [PubMed]
  105. Baba, Y.; Hayashi, K.; Fujii, Y.; Mizushima, A.; Watarai, H.; Wakamori, M.; Numaga, T.; Mori, Y.; Iino, M.; Hikida, M.; et al. Coupling of STIM1 to store-operated Ca2+ entry through its constitutive and inducible movement in the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 2006, 103, 16704–16709. [Google Scholar] [CrossRef] [PubMed]
  106. Sallinger, M.; Humer, C.; Ong, H.L.; Narayanasamy, S.; Lin, Q.T.; Fahrner, M.; Grabmayr, H.; Berlansky, S.; Choi, S.; Schmidt, T.; et al. Essential role of N-terminal SAM regions in STIM1 multimerization and function. Proc. Natl. Acad. Sci. USA 2024, 121, e2318874121. [Google Scholar] [CrossRef] [PubMed]
  107. Enomoto, M.; Nishikawa, T.; Back, S.I.; Ishiyama, N.; Zheng, L.; Stathopulos, P.B.; Ikura, M. Coordination of a Single Calcium Ion in the EF-hand Maintains the Off State of the Stromal Interaction Molecule Luminal Domain. J. Mol. Biol. 2020, 432, 367–383. [Google Scholar] [CrossRef] [PubMed]
  108. Sallinger, M.; Grabmayr, H.; Humer, C.; Bonhenry, D.; Romanin, C.; Schindl, R.; Derler, I. Activation mechanisms and structural dynamics of STIM proteins. J. Physiol. 2023, 602, 1475–1507. [Google Scholar] [CrossRef] [PubMed]
  109. Knight, M.J.; Leettola, C.; Gingery, M.; Li, H.; Bowie, J.U. A human sterile alpha motif domain polymerizome. Protein Sci. 2011, 20, 1697–1706. [Google Scholar] [CrossRef]
  110. Bohm, J.; Chevessier, F.; Koch, C.; Peche, G.A.; Mora, M.; Morandi, L.; Pasanisi, B.; Moroni, I.; Tasca, G.; Fattori, F.; et al. Clinical, histological and genetic characterisation of patients with tubular aggregate myopathy caused by mutations in STIM1. J. Med. Genet. 2014, 51, 824–833. [Google Scholar] [CrossRef]
  111. Bohm, J.; Chevessier, F.; Maues De Paula, A.; Koch, C.; Attarian, S.; Feger, C.; Hantai, D.; Laforet, P.; Ghorab, K.; Vallat, J.M.; et al. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am. J. Hum. Genet. 2013, 92, 271–278. [Google Scholar] [CrossRef]
  112. Walter, M.C.; Rossius, M.; Zitzelsberger, M.; Vorgerd, M.; Muller-Felber, W.; Ertl-Wagner, B.; Zhang, Y.; Brinkmeier, H.; Senderek, J.; Schoser, B. 50 years to diagnosis: Autosomal dominant tubular aggregate myopathy caused by a novel STIM1 mutation. Neuromuscul. Disord. 2015, 25, 577–584. [Google Scholar] [CrossRef]
  113. Hedberg, C.; Niceta, M.; Fattori, F.; Lindvall, B.; Ciolfi, A.; D’Amico, A.; Tasca, G.; Petrini, S.; Tulinius, M.; Tartaglia, M.; et al. Childhood onset tubular aggregate myopathy associated with de novo STIM1 mutations. J. Neurol. 2014, 261, 870–876. [Google Scholar] [CrossRef]
  114. Berna-Erro, A.; Jardin, I.; Salido, G.M.; Rosado, J.A. Role of STIM2 in cell function and physiopathology. J. Physiol. 2017, 595, 3111–3128. [Google Scholar] [CrossRef] [PubMed]
  115. Grosse, J.; Braun, A.; Varga-Szabo, D.; Beyersdorf, N.; Schneider, B.; Zeitlmann, L.; Hanke, P.; Schropp, P.; Muhlstedt, S.; Zorn, C.; et al. An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice. J. Clin. Investig. 2007, 117, 3540–3550. [Google Scholar] [CrossRef] [PubMed]
  116. Sallinger, M.; Tiffner, A.; Schmidt, T.; Bonhenry, D.; Waldherr, L.; Frischauf, I.; Lunz, V.; Derler, I.; Schober, R.; Schindl, R. Luminal STIM1 Mutants that Cause Tubular Aggregate Myopathy Promote Autophagic Processes. Int. J. Mol. Sci. 2020, 21, 4410. [Google Scholar] [CrossRef] [PubMed]
  117. Burgos, M.; Philippe, R.; Antigny, F.; Buscaglia, P.; Masson, E.; Mukherjee, S.; Dubar, P.; Le Marechal, C.; Campeotto, F.; Lebonvallet, N.; et al. The p.E152K-STIM1 mutation deregulates Ca2+ signaling contributing to chronic pancreatitis. J. Cell Sci. 2021, 134, jcs244012. [Google Scholar] [CrossRef]
  118. Schaballie, H.; Rodriguez, R.; Martin, E.; Moens, L.; Frans, G.; Lenoir, C.; Dutre, J.; Canioni, D.; Bossuyt, X.; Fischer, A.; et al. A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency. J. Allergy Clin. Immunol. 2015, 136, 816–819 e814. [Google Scholar] [CrossRef]
  119. Ticci, C.; Cassandrini, D.; Rubegni, A.; Riva, B.; Vattemi, G.; Mata, S.; Ricci, G.; Baldacci, J.; Guglielmi, V.; Di Muzio, A.; et al. Expanding the clinical and genetic spectrum of pathogenic variants in STIM1. Muscle Nerve 2021, 64, 567–575. [Google Scholar] [CrossRef]
  120. Landrum, M.J.; Lee, J.M.; Riley, G.R.; Jang, W.; Rubinstein, W.S.; Church, D.M.; Maglott, D.R. ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014, 42, D980–D985. [Google Scholar] [CrossRef]
  121. Berna-Erro, A.; Sanchez-Collado, J.; Nieto-Felipe, J.; Macias-Diaz, A.; Redondo, P.C.; Smani, T.; Lopez, J.J.; Jardin, I.; Rosado, J.A. The Ca2+ Sensor STIM in Human Diseases. Biomolecules 2023, 13, 1284. [Google Scholar] [CrossRef]
  122. Di, J.; Yenwongfai, L.; Rieger, H.T.; Zhang, S.; Wei, S. Familial 4p Interstitial Deletion Provides New Insights and Candidate Genes Underlying This Rare Condition. Genes 2023, 14, 635. [Google Scholar] [CrossRef]
  123. Chen, C.P.; Lee, M.J.; Chern, S.R.; Wu, P.S.; Su, J.W.; Chen, Y.T.; Lee, M.S.; Wang, W. Prenatal diagnosis and molecular cytogenetic characterization of a de novo proximal interstitial deletion of chromosome 4p (4p15.2-->p14). Gene 2013, 529, 351–356. [Google Scholar] [CrossRef]
  124. Crippa, M.; Malatesta, P.; Bonati, M.T.; Trapasso, F.; Fortunato, F.; Annesi, G.; Larizza, L.; Labate, A.; Finelli, P.; Perrotti, N.; et al. A familial t(4;8) translocation segregates with epilepsy and migraine with aura. Ann. Clin. Transl. Neurol. 2020, 7, 855–859. [Google Scholar] [CrossRef] [PubMed]
  125. Liang, L.; Xie, Y.; Shen, Y.; Yin, Q.; Yuan, H. A Rare de novo Interstitial Duplication at 4p15.2 in a Boy with Severe Congenital Heart Defects, Limb Anomalies, Hypogonadism, and Global Developmental Delay. Cytogenet. Genome Res. 2016, 150, 112–117. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Schematic representation of the activation of store-operated Ca2+ entry (SOCE). The cascade of molecular events leading to the ER-Ca2+ store depletion and the re-filling up of stores are shown here. STIM proteins are single-pass ER-TM proteins with their N-terminal domains (dashed boxes) within the ER lumen. The NMR structures for the N-terminal EF-SAM of STIM1 (PDB: 2K60 [27]) and STIM2 (PDB: 2L5Y [28]) are shown in dashed boxes. The N-terminus contains a canonical EF-hand (cEF; magenta), a non-canonical EF-hand (nEF; yellow), and a SAM domain (blue). GPCR, G-protein coupled receptor; PLC-ß, phospholipase C-ß; PIP2, phosphatidylinositol 4,5-bisphosphate; DAG, diacylglycerol; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor; ER, endoplasmic reticulum; SERCA, Sarco-ER Ca2+; TG, thapsigargin.
Figure 1. Schematic representation of the activation of store-operated Ca2+ entry (SOCE). The cascade of molecular events leading to the ER-Ca2+ store depletion and the re-filling up of stores are shown here. STIM proteins are single-pass ER-TM proteins with their N-terminal domains (dashed boxes) within the ER lumen. The NMR structures for the N-terminal EF-SAM of STIM1 (PDB: 2K60 [27]) and STIM2 (PDB: 2L5Y [28]) are shown in dashed boxes. The N-terminus contains a canonical EF-hand (cEF; magenta), a non-canonical EF-hand (nEF; yellow), and a SAM domain (blue). GPCR, G-protein coupled receptor; PLC-ß, phospholipase C-ß; PIP2, phosphatidylinositol 4,5-bisphosphate; DAG, diacylglycerol; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor; ER, endoplasmic reticulum; SERCA, Sarco-ER Ca2+; TG, thapsigargin.
Biomolecules 14 01200 g001
Figure 2. Multiple sequence alignment of STIM1 homologs. Multiple sequence alignment of STIM1 was generated in the MAFFT alignment tool employing BLAST search using human STIM1 (Uniprotkb: Q13586) as a query sequence. The amino acids in the cEF loop and nEF are highly conserved among STIM1 orthologs, shown as red and olive green, respectively. Any variations in the consensus sequence within the loop regions are marked by different colors (dark blue, positively charged amino acids; light green, negatively charged amino acids; light blue, polar uncharged amino acids; turquoise blue, hydrophobic amino acids). Protein sequences of STIM2 (human), STIM from Worm (C. elegans), and Fruit fly (D. melanogaster) were also included in the alignment, shown as #, *, and $, respectively.
Figure 2. Multiple sequence alignment of STIM1 homologs. Multiple sequence alignment of STIM1 was generated in the MAFFT alignment tool employing BLAST search using human STIM1 (Uniprotkb: Q13586) as a query sequence. The amino acids in the cEF loop and nEF are highly conserved among STIM1 orthologs, shown as red and olive green, respectively. Any variations in the consensus sequence within the loop regions are marked by different colors (dark blue, positively charged amino acids; light green, negatively charged amino acids; light blue, polar uncharged amino acids; turquoise blue, hydrophobic amino acids). Protein sequences of STIM2 (human), STIM from Worm (C. elegans), and Fruit fly (D. melanogaster) were also included in the alignment, shown as #, *, and $, respectively.
Biomolecules 14 01200 g002
Figure 3. Gain of function (GoF) mutations leading to TAM/York platelet syndrome in canonical (panel (a)) and non-canonical (panel (b)) EF-hands of STIM1 (PDB: 2K60 [27]). TAM mutations are indicated by either dashed/solid black boxes; the dashed black box around the mutants indicates mutations in the entering/exiting helix. A solid black box indicates mutations in the loop region. The numbers within the paratheses of the mutants represent the position of these amino acids in a typical EF-hand motif; the I115F mutant, seen in both TAM and York platelet syndrome, is shown as an orange box.
Figure 3. Gain of function (GoF) mutations leading to TAM/York platelet syndrome in canonical (panel (a)) and non-canonical (panel (b)) EF-hands of STIM1 (PDB: 2K60 [27]). TAM mutations are indicated by either dashed/solid black boxes; the dashed black box around the mutants indicates mutations in the entering/exiting helix. A solid black box indicates mutations in the loop region. The numbers within the paratheses of the mutants represent the position of these amino acids in a typical EF-hand motif; the I115F mutant, seen in both TAM and York platelet syndrome, is shown as an orange box.
Biomolecules 14 01200 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Narayanasamy, S.; Ong, H.L.; Ambudkar, I.S. A Deep Dive into the N-Terminus of STIM Proteins: Structure–Function Analysis and Evolutionary Significance of the Functional Domains. Biomolecules 2024, 14, 1200. https://doi.org/10.3390/biom14101200

AMA Style

Narayanasamy S, Ong HL, Ambudkar IS. A Deep Dive into the N-Terminus of STIM Proteins: Structure–Function Analysis and Evolutionary Significance of the Functional Domains. Biomolecules. 2024; 14(10):1200. https://doi.org/10.3390/biom14101200

Chicago/Turabian Style

Narayanasamy, Sasirekha, Hwei Ling Ong, and Indu S. Ambudkar. 2024. "A Deep Dive into the N-Terminus of STIM Proteins: Structure–Function Analysis and Evolutionary Significance of the Functional Domains" Biomolecules 14, no. 10: 1200. https://doi.org/10.3390/biom14101200

APA Style

Narayanasamy, S., Ong, H. L., & Ambudkar, I. S. (2024). A Deep Dive into the N-Terminus of STIM Proteins: Structure–Function Analysis and Evolutionary Significance of the Functional Domains. Biomolecules, 14(10), 1200. https://doi.org/10.3390/biom14101200

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop